MEET POWERFUL SAVINGS1,2
POWERFUL PRODUCTS
MEET POWERFUL SAVINGS1,2
Savings & Financial
Support
Find your savings program
Powerful hypertension treatment1,2 can be within reach—and within budget. Reduce the out-of-pocket costs of EDARBI® (azilsartan medoxomil) and EDARBYCLOR® (azilsartan medoxomil/chlorthalidone) through one of our savings programs.
If eligible, you can access savings regardless of insurance coverage. There are options for you whether you are insured, noninsured, or cash-paying.
$15/month*
Cash-Pay Program*†
Eligibility requirements for patients utilizing insurance: This offer cannot be used if a patient is a beneficiary of, or any part of their prescription is covered by: (1) any federal or state healthcare program (Medicare, Medicaid, TriCARE, etc.), including a state pharmaceutical assistance program; (2) the Medicare Prescription Drug Program (Part D), or if the patient is currently in the coverage gap; or (3) has insurance that is paying the entire cost of the prescription. Offer is void where prohibited by law.
Any patient may opt to take advantage of Azurity’s cash-payment programs; patients must attest the claim is not being billed through insurance. Prescriptions for cash-paying patients will be triaged to Azurity Patient Direct, which is fulfilled by Truax Patient Services. You will receive a call from Truax Patient Services or you may call (844) 289-3981 to inquire about your prescription.
Copay Savings Card
Save at a pharmacy of your choice
If you’re a commercially insured patient, use our Copay Savings Card and pay as little as $15* for EDARBI or EDARBYCLOR prescriptions. Use these instant savings at any pharmacy of your choice.
WELCOME TO THE EDARBI® (AZILSARTAN MEDOXOMIL) AND EDARBYCLOR® (AZILSARTAN MEDOXOMIL/CHLORTHALIDONE) COPAY SAVINGS CARD PROGRAM
FOR PATIENTS: If your copay for EDARBI or EDARBYCLOR exceeds $15 (insured patients) present this card to the pharmacist for an instant rebate.* Benefit limitations apply. Patient is responsible for the remaining balance after benefit limits are reached. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday).
FOR PHARMACISTS: Benefit limitations apply.* Additional program details are available at www.edarbi.com. When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. By redeeming this coupon, you agree that you understand and will abide by the terms and conditions of this offer, posted at www.mckesson.com/mprstnc.
WELCOME TO THE SAVINGS PROGRAM!
Your savings card should download in a few seconds. If not, click here to download your savings card.EDARBI and EDARBYCLOR Copay Savings Program Terms and Conditions
To the Patient: If your copay for EDARBI or EDARBYCLOR exceeds $15 (insured patients), present this card to the pharmacist for an instant rebate. Benefit limitations apply. Patient is responsible for the remaining balance after benefit limits are reached. For questions regarding your eligibility or benefits or if you wish to discontinue your participation, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday).
To the Pharmacist: Benefit limitations apply. Additional program details are available at www.edarbi.com. When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. By redeeming this coupon, you agree that you understand and will abide by the terms and conditions of this offer, posted at www.mckesson.com/mprstnc.
For questions regarding setup, claim transmission, patient eligibility, or other issues, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday).
1. White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011;57(3):413-420. doi:10.1161/HYPERTENSIONAHA.110.163402
2. Cushman WC, Bakris GL, White WB, et al. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension. 2012;60(2):310-318.